Water Quality in HOUSTON, TX (77094)
EPA violation data for public water systems serving ZIP code 77094.
1,448
Total Violations
105
Health-Based
1,343
Monitoring / Reporting
1,331
Resolved
What does this mean?
1,331 of 1,448 violations have been resolved. 105 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 1,343 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (1448 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Nitrate | Health-Based | N/A | 17 | Jun 30, 2025 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 9, 2025 | Active | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2025 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2025 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2025 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Nitrate | Health-Based | N/A | 20 | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 20 | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 11, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 11, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 22 | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 22 | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 22 | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 18 | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Nitrate | Health-Based | N/A | 18 | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 18 | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 27, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 4, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 4, 2024 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 23 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 23 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 23 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Nitrate | Health-Based | N/A | 19 | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 19 | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 19 | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 1, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 1, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 20 | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 6, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 6, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 6, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 6, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 21 | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 21 | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 21 | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 14, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 14, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 14, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 14, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 18 | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 15, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 15, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 15, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 15, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 15, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 21, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 21, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 21, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 16 | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 16 | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 16 | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 16 | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Health-Based | N/A | 16 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Health-Based | N/A | 16 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 16 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 16 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 19, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 14 | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 14 | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 14 | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 14 | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 17, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 18, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 12 | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 12 | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Health-Based | N/A | 12 | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 12 | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 18, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Nitrate | Health-Based | N/A | 17 | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 17 | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 17 | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Public Notice | Monitoring | N/A | N/A | Mar 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(106)
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Nitrate
01
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
01
Nitrate
01
Chlorine
27
Nitrate
01
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Revised Total Coliform Rule
3A
Chlorine
27
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
2024(123)
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
01
Nitrate
01
Arsenic
02
Arsenic
02
Nitrate
01
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
Public Notice
75
Public Notice
75
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Arsenic
02
Arsenic
02
Nitrate
01
Nitrate
01
Nitrate
01
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Lead and Copper Rule
66
Lead and Copper Rule
66
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Consumer Confidence Rule
71
Lead and Copper Rule
53
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
53
Nitrate
01
Lead and Copper Rule
52
Nitrate
03
Arsenic
02
Arsenic
02
Nitrate
03
Nitrate
03
Lead and Copper Rule
52
Nitrate
01
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
01
Nitrate
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
02
Arsenic
03
Nitrate
01
Nitrate
01
Arsenic
03
Arsenic
03
Arsenic
02
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
01
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2023(263)
Tetrachloroethylene
03
Carbon tetrachloride
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
Tetrachloroethylene
03
Trichloroethylene
03
DICHLOROMETHANE
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
DICHLOROMETHANE
03
CHLOROBENZENE
03
Xylenes, Total
03
Xylenes, Total
03
Toluene
03
Styrene
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
Ethylbenzene
03
Ethylbenzene
03
Styrene
03
Lead and Copper Rule
53
Toluene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
1,1-Dichloroethylene
03
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
trans-1,2-Dichloroethylene
03
1,1-Dichloroethylene
03
1,2,4-Trichlorobenzene
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
cis-1,2-Dichloroethylene
03
Benzene
03
Benzene
03
Nitrate
03
Nitrate
03
1,2,4-Trichlorobenzene
03
Trichloroethylene
03
trans-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
Arsenic
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
01
Nitrate
01
Nitrate
01
Arsenic
02
1,1,1-Trichloroethane
03
Nitrite
03
Xylenes, Total
03
Xylenes, Total
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
Nitrate
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Ethylbenzene
03
Ethylbenzene
03
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
cis-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
TTHM
27
TTHM
27
trans-1,2-Dichloroethylene
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Benzene
03
Benzene
03
Tetrachloroethylene
03
Toluene
03
Toluene
03
Tetrachloroethylene
03
Trichloroethylene
03
1,2-Dichloropropane
03
Trichloroethylene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Styrene
03
Styrene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Carbon tetrachloride
03
1,2-Dichloropropane
03
Carbon tetrachloride
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Vinyl chloride
03
Vinyl chloride
03
Nitrate
03
Nitrite
03
cis-1,2-Dichloroethylene
03
Total Haloacetic Acids (HAA5)
27
Nitrate
03
Total Haloacetic Acids (HAA5)
27
Nitrate
03
TTHM
27
TTHM
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
01
Nitrate
03
Nitrate
01
Nitrate
01
Nitrate
03
Public Notice
75
Public Notice
75
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
01
Arsenic
03
Public Notice
75
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Arsenic
03
Arsenic
03
Nitrate
01
Nitrate
01
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Public Notice
75
Nitrate
01
Nitrate
01
Nitrate
01
Nitrate
03
Nitrate
03
Nitrate
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2022(498)
1,1-Dichloroethylene
03
CHLOROBENZENE
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Benzene
03
Benzene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
1,1-Dichloroethylene
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Trichloroethylene
03
Trichloroethylene
03
Vinyl chloride
03
Vinyl chloride
03
Nitrate
03
Nitrate
03
Styrene
03
Styrene
03
Ethylbenzene
03
Ethylbenzene
03
Toluene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
DICHLOROMETHANE
03
DICHLOROMETHANE
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Xylenes, Total
03
Xylenes, Total
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
Toluene
03
Arsenic
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
02
Nitrate
03
Nitrate
01
Nitrate
01
Nitrate
01
Arsenic
02
Nitrate
03
Nitrate
03
Public Notice
75
Public Notice
75
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Arsenic
02
Xylenes, Total
03
Tetrachloroethylene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
Toluene
03
Toluene
03
Xylenes, Total
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Nitrite
03
1,2-Dichloropropane
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Nitrite
03
Vinyl chloride
03
Vinyl chloride
03
Public Notice
75
Public Notice
75
Toluene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Styrene
03
Styrene
03
Styrene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Nitrate
03
Nitrate
03
Nitrate
03
Vinyl chloride
03
Carbon tetrachloride
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Carbon tetrachloride
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
Carbon tetrachloride
03
trans-1,2-Dichloroethylene
03
1,1,1-Trichloroethane
03
Tetrachloroethylene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
Ethylbenzene
03
Ethylbenzene
03
Ethylbenzene
03
Nitrite
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,1,2-Trichloroethane
03
Benzene
03
Benzene
03
Benzene
03
Tetrachloroethylene
03
Xylenes, Total
03
Xylenes, Total
03
trans-1,2-Dichloroethylene
03
1,2-Dichloropropane
03
Benzene
03
Benzene
03
Benzene
03
Benzene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Vinyl chloride
03
Vinyl chloride
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Xylenes, Total
03
Xylenes, Total
03
Xylenes, Total
03
Tetrachloroethylene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Ethylbenzene
03
Ethylbenzene
03
Ethylbenzene
03
Ethylbenzene
03
Styrene
03
Styrene
03
Styrene
03
Styrene
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Toluene
03
Toluene
03
Toluene
03
Toluene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,2-Dichloropropane
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
01
Nitrate
01
Nitrate
01
Nitrate
01
Nitrate
03
Arsenic
03
Arsenic
03
Public Notice
75
Public Notice
75
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Lead and Copper Rule
53
Lead and Copper Rule
53
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Lead and Copper Rule
53
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Nitrate
03
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Public Notice
75
Consumer Confidence Rule
71
Nitrate
03
Nitrate
01
Nitrate
01
Nitrate
01
Nitrate
01
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Lead and Copper Rule
52
Public Notice
75
Public Notice
75
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
01
Nitrate
01
Nitrate
03
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Nitrate
03
Arsenic
02
Nitrate
03
Nitrate
03
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
01
Nitrate
01
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2021(458)
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Fluoride
03
Fluoride
03
Nitrate
01
Arsenic
02
Arsenic
03
Arsenic
03
Nitrate
03
Fluoride
03
Nitrate
01
Nitrate
03
Nitrate
03
Arsenic
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Nitrate
01
Nitrate
01
Vinyl chloride
03
1,2-Dichloroethane
03
Trichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
Carbon tetrachloride
03
Carbon tetrachloride
03
DICHLOROMETHANE
03
1,1,1-Trichloroethane
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
cis-1,2-Dichloroethylene
03
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
1,2-Dichloropropane
03
Public Notice
75
1,2-Dichloropropane
03
1,2-Dichloropropane
03
Xylenes, Total
03
Xylenes, Total
03
Xylenes, Total
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Tetrachloroethylene
03
1,2-Dichloroethane
03
Trichloroethylene
03
Lead and Copper Rule
52
Nitrite
03
Lead and Copper Rule
52
DICHLOROMETHANE
03
Benzene
03
Benzene
03
Benzene
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CYANIDE
03
CYANIDE
03
Toluene
03
Toluene
03
Toluene
03
Ethylbenzene
03
Nitrite
03
Nitrite
03
Ethylbenzene
03
Ethylbenzene
03
Styrene
03
Styrene
03
Styrene
03
Tetrachloroethylene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Nitrate
03
Nitrate
03
Tetrachloroethylene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
1,1-Dichloroethylene
03
DICHLOROMETHANE
03
Vinyl chloride
03
Vinyl chloride
03
1,2,4-Trichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Trichloroethylene
03
cis-1,2-Dichloroethylene
03
Carbon tetrachloride
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
cis-1,2-Dichloroethylene
03
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Nitrate
03
Arsenic
02
Nitrate
01
Nitrate
01
Nitrate
01
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
02
Nitrate
03
Nitrate
03
Chlorine
27
Chlorine
27
Arsenic
02
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Nitrate
01
Public Notice
75
Total Haloacetic Acids (HAA5)
27
Public Notice
75
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
TTHM
27
TTHM
27
Revised Total Coliform Rule
3A
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Revised Total Coliform Rule
3A
TTHM
27
Revised Total Coliform Rule
3A
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Chlorine
27
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
53
Lead and Copper Rule
52
Chlorine
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Chlorine
27
Chlorine
27
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
01
Nitrate
01
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Arsenic
02
Arsenic
02
Chlorine
27
Chlorine
27
Chlorine
27
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Arsenic
02
Arsenic
02
Nitrate
01
Lead and Copper Rule
52
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Nitrate
01
Revised Total Coliform Rule
3A
Chlorine
27
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Chlorine
27
Lead and Copper Rule
52
Chlorine
27
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Lead and Copper Rule
52
Lead and Copper Rule
52
Consumer Confidence Rule
71
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Arsenic
03
Chlorine
27
Chlorine
27
Chlorine
27
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Nitrate
01
Nitrate
01
Revised Total Coliform Rule
3A
Nitrate
01
Nitrate
01
Revised Total Coliform Rule
3A
Chlorine
27
Public Notice
75
Public Notice
75
Public Notice
75
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
How Does This Compare?
HOUSTON (77094) has 1,448 recorded violations, including 105 health-based. 117 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.